# POP: 2/22/17-2/21/21. PRECLINICAL MEDICATIONS DISCOVERY AND ABUSE LIABILITY TESTING FOR NIDA. N01DA-17-8932. PURPOSE: TO EXERCISE OPTION QUANTITY 1(CO

> **NIH NIH N01** · VIRGINIA COMMONWEALTH UNIVERSITY · 2020 · $968,474

## Abstract

This contract provides support for evaluation of potential pharmacotherapies for drug dependence disorders in both rodents and primates. It also provides support for abuse liability-related testing of new street drugs, medications, or potential medications in rodents and primates. The primary emphasis is on testing conducted for NIDA's Addiction Treatment Discovery Program (ATDP). To a lesser extent, the contract will generate abuse liability data for use in decisions pertaining to scheduling of drugs under domestic laws (Controlled Substances Act) and international treaties (Single Convention and Psychotropic Convention). NIDA's testing needs for this contract will be dynamic, due to the influences of such factors as opportunities for NIDA/pharmaceutical company collaboration, advances in the field of drug addiction research, and advice from consultants to the ATDP.

## Key facts

- **NIH application ID:** 10285106
- **Project number:** 271201700008C-P00007-9999-2
- **Recipient organization:** VIRGINIA COMMONWEALTH UNIVERSITY
- **Principal Investigator:** PATRICK BEARDSLEY
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $968,474
- **Award type:** —
- **Project period:** 2017-02-22 → 2021-02-21

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10285106

## Citation

> US National Institutes of Health, RePORTER application 10285106, POP: 2/22/17-2/21/21. PRECLINICAL MEDICATIONS DISCOVERY AND ABUSE LIABILITY TESTING FOR NIDA. N01DA-17-8932. PURPOSE: TO EXERCISE OPTION QUANTITY 1(CO (271201700008C-P00007-9999-2). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10285106. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*